NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (the "Company") (NASDAQ:NHP) announced today that it will redeem all of the outstanding (i) 3,289,061 shares of its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (CUSIP: 42226B204) (the "Series A Preferred Stock") and (ii) 2,850,427 shares of its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock (CUSIP: 42226B303) (the "Series B Preferred Stock" and, together with the Series A Preferred Stock, the "Outstanding Preferred Stock"), at redemption prices equal to $25.00 per share of Outstanding Preferred Stock, plus any accrued and unpaid dividends thereon to, but not including, September 4, 2026 for the Series A Preferred Stock and October 6, 2026 for the Series B Preferred Stock (each, a "Redemption Date"). The Series A Preferred Stock and the Series B Preferred Stock currently trade under ticker symbols "NHPAP" and "NHPBP", respectively.

Notices of Redemption for the Series A Preferred Stock and the Series B Preferred Stock will be sent to their respective holders on August 5, 2026 and August 7, 2026, respectively. Additional information related to the procedures for the redemptions, including copies of the Notices of Redemption, may be obtained from Computershare Trust Company, N.A. by calling 888-796-2490 or by emailing web.queries@computershare.com.

About National Healthcare Properties

National Healthcare Properties, Inc. (NASDAQ:NHP) is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States. Additional information about the Company can be found on its website at nhpreit.com.

Investor & Media Contact

Email: ir@nhpreit.com

Cautionary Statement Regarding Forward-Looking Statements

This press release may contain "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of terminology such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "seek," "will," "may," "should," "predict," "project," "potential," "continue" or the negatives of these terms or variations of them or similar expressions. Risks and uncertainties, the occurrence of which could adversely affect the Company’s business and cause actual results to differ materially from those expressed or implied in the forward-looking statements, include, but are not limited to, the following: changes in economic cycles generally and in the real estate and healthcare markets specifically; the success of the Company’s growth strategy, including its ability to successfully identify, complete and integrate new acquisitions; the Company’s ability to complete acquisitions or dispositions on the terms and timing the Company expects, or at all; changes to inflation and interest rates; competition in the real estate and healthcare markets; the Company’s ability to retain certain key personnel; legislative and regulatory changes in the healthcare and real estate industries; reductions or changes in reimbursement from third-party payors, including Medicare and Medicaid; discovery of previously undetected environmentally hazardous conditions; the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; system failures, cyber incidents or deficiencies in the Company’s cybersecurity systems; the availability of capital on favorable terms, or at all; the Company’s ability to remain qualified as a real estate investment trust for U.S. federal income tax purposes; and other risks and uncertainties described in the section titled Risk Factors of the Company’s most recent Annual Report on Form 10-K and all other filings with the Securities and Exchange Commission. Finally, the Company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.